Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222514 · ClinicalTrials.gov registry record · NA
Feasibility and Safety of Single-Port Robotic-Assisted Deep Inferior Epigastric Pedicle Flap Harvest
A NA study of DIEP Flap Breast Reconstruction, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT07222514: Recruiting NA study of DIEP Flap Breast Reconstruction, sponsored by Vanderbilt University Medical Center.
NCT07222514 is a NA study of DIEP Flap Breast Reconstruction that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07222514, a NA study of DIEP Flap Breast Reconstruction, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to evaluate the feasibility of single-port robotic surgery for DIEP flap breast reconstruction. The investigators will also investigate complications of the procedure, incision length, flap success rate, post operative pain, vascular pedicle length and caliber, and VMP-B score (quality of life/satisfaction of breast procedures survey).
Primary Outcome
This will be "Yes" if the following are true of the procedure: completed pedicle dissection using the robotic system, adequate pedicle dissected, and no intraoperative complication requiring conversion to the open approach.
Conditions Studied
Interventions
- DEVICE Single-Port Robotic System
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2026-02 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07222514 shows while recruiting
NCT07222514 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with DIEP Flap Breast Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Single-Port Robotic System is the first listed.
NCT07222514 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT07222514 about?
NCT07222514 is a clinical study titled "Feasibility and Safety of Single-Port Robotic-Assisted Deep Inferior Epigastric Pedicle Flap Harvest". The primary aim of this study is to evaluate the feasibility of single-port robotic surgery for DIEP flap breast reconstruction. The investigators will also investigate complications of the procedure, incision length, flap success rate, post operative pain, vascular pedicle length and caliber, and V...
What is the current status of trial NCT07222514?
This trial is currently recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2026-02. Estimated completion is 2027-12.
What conditions does trial NCT07222514 study?
This clinical trial studies the following conditions: DIEP Flap Breast Reconstruction.
What interventions are being tested in trial NCT07222514?
The interventions under investigation include: Single-Port Robotic System (DEVICE).
Who is sponsoring clinical trial NCT07222514?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222514 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07222514's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia